Mackenzie is an Immunotherapy Project Manager in the Office of Entrepreneurship & Commercialization (OEC), which she joined in April 2026. In this role, she supports the licensing, commercialization, and marketing of MSK technology, helping to advance breakthrough discoveries from the laboratory to the marketplace.
Prior to joining OEC, Mackenzie served as a Consulting Project Manager at Guidepoint, where she focused on healthcare market research and investment strategy, supporting clients with insights across the healthcare landscape.
Mackenzie holds a Bachelor’s degree in International Relations and Spanish from Bucknell University.